Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

By | November 22, 2022
In a recent study published in the journal Advanced Science, researchers developed molecularly imprinted nanoparticles (nanoMIPs) with broad-spectrum activity against lethal viruses.